Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Medical Protein Therapeutic Supply (Albumin Human 25%)

Active

Federal

Response Deadline07/29/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the supply of 10 units of Albumin Human USP 25% 50mL, heat-treated for intravenous use, which must comply with United States Pharmacopeia standards and be provided ready for immediate use at the destination. Each unit includes necessary administration accessories to support safe and efficient delivery. The product is intended for medical use within the Department of Defense supply chain, with performance required at Fort Bragg, North Carolina, under the procurement code 325413 for pharmaceutical preparations. The solicitation was posted on July 23, 2026, and all responses must be submitted by July 29, 2026. It is classified as a subcontract under the Medical Supply Chain Pharm FSA, managed by the Department of Defense. While no set-aside designation or point of contact is specified, the contract is accessible via the DIBBS platform for vendor submissions, and all materials must meet stringent regulatory and logistical requirements to ensure usability in military medical facilities.

General Info

10 units Albumin Human USP 25% 50mL for DoD at Fort Bragg, must comply with USP standards, ready for immediate use.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 23

subcontract

Response DeadlineJul 29

Submission deadline

Response Deadline

07/29/2026, 05:00:00 PM UTCin 2 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of 10 units (PG) of Albumin Human USP 25% 50mL, heat-treated, with administration accessories, for intravenous use. Must meet USP standards and be delivered ready for destination use.

Similar Contracts

Same NAICS industry code

Combined Synopsis Solicitation- Acquire 32-sample The National Institutes of Health, through the Department of Health and Human Services, is soliciting proposals under a non-competitive combined synopsis and solicitation for the acquisition of a 32-sample product, identified by solicitation number 75N98026Q00881. This procurement is conducted under FAR Part 12.603 as a streamlined process for commercial items and falls below the simplified acquisition threshold, utilizing statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify the absence of full and open competition. The solicitation is issued as a Notice of Intent and serves as the only formal request for proposals, with no additional written solicitation to follow. Proposals must be submitted by the deadline of August 3, 2026, at 6:00 p.m. Eastern Time, following the posting date of July 27, 2026. The contracting activity is managed by the Office of Acquisition and Logistics Operations in Bethesda, Maryland, with the NAICS code 325413 indicating the product relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Cassie M. Runner, reachable via email at cassie.runner@nih.gov or phone at 301-480-8827. The place of performance has not been specified, but the contract award will be directed toward a commercial supplier capable of meeting requirements without competitive bidding, in alignment with the streamlined procedures and statutory exceptions under federal acquisition regulations. All responses must comply with the terms outlined in the combined synopsis, and no further documentation will be issued beyond this notice.

National Institutes Of Health Olao

POSTED

about 11 hours ago

DEADLINE

TEST KIT, CORONAVIRUS DThe contract specifies the procurement of 3 cases of Abbott BinaxNOW COVID-19 Antigen Self Test kits, each case containing 12 kits with two tests per kit, for at-home, over-the-counter use. Each test kit must be stored between 2 and 30 degrees Celsius and is subject to a strict 12-month shelf life with no extensions permitted; no more than one month may have passed from the date of manufacture to the date of delivery to the government. All kits must be labeled with the date of manufacture, expiration or retest date, and the contract and lot numbers in compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, ensuring protection from damage and safe delivery via common carrier to the designated delivery point in FPO, 96674, while minimizing shipping costs. The item is identified by NSN 6550-01-716-1573 under solicitation SPE2DS-26-T-269U, with a 20-day delivery requirement and a response deadline of August 3, 2026. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and the procurement is subject to covered defense information protocols and DLA packaging standards.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL LOOP SETThe contract is for a CONTROL LOOP SET, specifically designed for microbiology use with Streptococcus pyogenes ATCC 19615, requiring refrigerated storage between 2°C and 8°C (36°F to 46°F) and prohibiting freezing. Each package contains five units, sold as a single purchasing unit (PG), and the item carries a non-extendable shelf life of 15 months, with no more than two months allowed to have elapsed from the date of manufacture to delivery. All labeling must comply with MMS1C, including explicit markings for the date of manufacture, expiration or retest date, and the contract or lot number. Packaging guidelines follow commercial standards and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions; exterior shipping containers must ensure safe delivery at the lowest freight rate using traceable carriers, with parcel post strictly prohibited. The item is governed by a suite of DFARS and FAR clauses, including requirements for safeguarding covered defense information, cyber incident reporting, NIST SP 800-171 compliance, and restrictions on covered telecommunications equipment. Transportation must comply with maritime regulations favoring U.S.-flag vessels. Quality and technical specifications are derived from the DLA Master List of Technical and Quality Requirements, and packaging must meet RP001 DLA standards, including proper preservation per MIL-STD-2073-1E to maintain product integrity. The item is subject to destination inspection under FAR 52.246-2, with acceptance performed by the Government. The solicitation, issued under number SPE2DS-26-T-270X, has a response deadline of August 3, 2026, and requires electronic submission via DIBBS. The delivery point is identified as a Department of Defense address in Hampton, Virginia, with an overall delivery window of 20 days after the actual delivery order. Pricing varies by quantity, with extended contract values reaching up to $11,853.76 based on multiple line items. Contractors must have an active UEI and CAGE code, represent their size and socioeconomic status accurately, and comply with anti-trafficking, employment eligibility, and sustainable product requirements. All payment submissions must be processed through WAWF, and the contract prohibits the use of mandatory arbitration agreements and restricts compensation for former DoD officials.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche Flu Surveillance Testing ReagentThe contract anticipates the procurement of testing reagents for influenza surveillance under the Forensic Sciences Division of the District of Columbia for fiscal year 2026. The initiative is part of a broader public health effort to monitor flu activity, with reagents intended for use in diagnostic and surveillance testing. While specific quantities, delivery timelines, or technical specifications are not detailed in the forecast, the reagents will support laboratory-based detection and analysis of influenza strains across the jurisdiction. This procurement is categorized as a forecast, indicating it is a planning tool for vendors to prepare for an upcoming solicitation, and no formal solicitation number has been issued as of the posting date. The agency responsible, DFS, is based in Washington D.C., and performance is expected to occur within the district, though no specific location is provided. Vendors interested in participating should monitor future official solicitations, as this forecast serves only as an early indicator of intent and does not constitute a binding request for proposals.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Cepheid Norovirus, Mpox, Multiplex ReagentThe contract pertains to the acquisition of testing supplies specifically for the Cepheid Norovirus, Mpox, and Multiplex reagents under the Fiscal Year 2026 forecast for the Department of Forensic Sciences in the District of Columbia. It is categorized as a forecast listing, indicating it is a planned procurement rather than an active solicitation, with no formal solicitation number assigned at this time. The primary focus is on reagents used in diagnostic testing to support forensic and public health laboratories, likely to enhance detection capabilities for infectious agents relevant to criminal investigations and community health monitoring. There is no designated set-aside type, NAICS code, or organizational type specified, and the agency details are limited to the Forensic Sciences division within the District of Columbia, with no明确 office address or place of performance provided. No point of contact information is listed, and the contract remains in a pre-solicitation phase, intended to inform potential vendors of upcoming procurement needs. The associated UI link provides access to the official forecast posting for further details as the procurement process advances.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Qiagen reagentsThe contract forecasts the procurement of Qiagen reagents for forensic science testing applications under the Fiscal Year 2026 budget cycle, managed by the Forensic Sciences division within the District of Columbia. This initiative is tied to laboratory operations requiring reliable molecular diagnostics reagents, likely supporting DNA analysis, sample preparation, or other forensic testing workflows essential to criminal investigations and evidence processing. While the solicitation number and procurement details are not yet available, the posting date indicates this is a future forecast with no set-aside provisions indicated, meaning the opportunity is open to all eligible vendors without geographic or size-based restrictions. The place of performance and organizational details remain unspecified, but the activity is centered within the District of Columbia’s forensic system, suggesting delivery and use will occur at state or local forensic laboratories. No point of contact information is provided at this stage, and the NAICS code, office address, and other typical contracting metadata are also absent, indicating this is an early-stage forecast meant for market research and vendor awareness. Interested suppliers should monitor the official DC contracting portal for future solicitations tied to this forecast, as detailed requirements, timelines, and ordering procedures will be released in subsequent procurement actions.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - IDT Sequencing ReagentThe contract forecast pertains to the procurement of sequencing reagents for the Forensic Sciences Division of the District of Columbia, scheduled for fiscal year 2026. The solicitation is intended to support forensic DNA analysis operations, with the reagents critical to maintaining the accuracy and efficiency of sequencing workflows used in criminal investigations and evidence processing. Despite the lack of specific solicitation numbers, NAICS codes, or set-aside details, the anticipated procurement reflects an ongoing operational need within the agency’s forensic laboratory capabilities. The place of performance and point of contact information are currently unspecified, suggesting the details are still under development or will be finalized closer to the formal solicitation release. The posting date indicates the forecast is publicly available to potential vendors as an early notification ahead of a future bid opportunity, allowing suppliers to prepare proposals and align their offerings with the agency’s requirements.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Illumina AMD reagentsThe District of Columbia’s Forensic Sciences Division is forecasting procurement needs for AMD testing reagents in fiscal year 2026, with the solicitation posted on July 23, 2026. This forecast indicates an upcoming requirement for reagents used in forensic DNA analysis, likely supporting laboratory operations for criminal investigations and evidence processing. The contract is intended for Illumina-branded AMD reagents, suggesting a specific technology platform is preferred for genotyping or sequencing applications in the forensic context. Although the solicitation number, NAICS code, set-aside details, and office location are not yet specified, the procurement is being managed under the agency’s procurement portal and will likely proceed through a formal competitive process. Performance is expected to be delivered within the District of Columbia, aligning with the agency’s operational base. Interested vendors should monitor the official contract portal for the eventual release of a formal request for proposal, as this forecast serves as a preliminary notice to prepare for potential bidding opportunities.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Other Microbiology Testing ReagentsThe contract pertains to the procurement of microbiology testing reagents for the Forensic Sciences division of the District of Columbia, scheduled for fiscal year 2026. It is posted as a forecast with no solicitation number yet assigned, indicating it is a planning notice rather than an active bid opportunity. The reagents are intended to support forensic microbiology analyses, likely for use in criminal investigations, public health investigations, or other forensic science applications requiring precise microbial identification and analysis. There is no information provided on set-aside status, NAICS code, or specific organizational type, and the place of performance and point of contact details are incomplete or unlisted. The forecast was published on July 23, 2026, and is accessible via the District of Columbia’s contracts portal, suggesting that interested vendors should monitor for a formal solicitation in the near future.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche testing reagentsThe contract pertains to the procurement of Roche testing reagents for the Fiscal Year 2026 forecasting period under the Forensic Sciences Division of the District of Columbia. It is classified as a forecast notice, indicating a planned future procurement rather than an active solicitation, with no specific solicitation number assigned at this time. The reagents are intended for use in forensic laboratory testing and are likely required to support ongoing or anticipated casework involving DNA analysis, toxicology, or other forensic diagnostic applications. The agency responsible is the District of Columbia’s Forensic Sciences office, with no set-aside designation or NAICS code listed, suggesting the procurement may be open to general competition without specific small business or other socioeconomic preferences. The place of performance and point of contact information are not provided, and the only available link directs to the District’s contracts portal for further details. This forecast serves as early notice to potential suppliers to prepare for an upcoming solicitation.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Varies LRN-C Testing ReagentsThe contract focuses on the procurement of LRN-C testing reagents for fiscal year 2026 under the Forensic Sciences division of the District of Columbia, aimed at supporting laboratory testing capabilities. While specific reagent types and quantities are not detailed, the solicitation is classified as a forecast indicating future intent to procure, with no formal solicitation number yet assigned. The funding and requirements are tied to the Department of Public Health's forensic objectives, likely to ensure readiness for public health emergencies or forensic investigations requiring certified laboratory analysis. No set-aside provisions, NAICS codes, or point of contact information are provided at this stage, and the place of performance remains unspecified, though the agency location implies delivery within the District of Columbia. This forecast allows vendors to prepare for potential future bidding opportunities, with the official solicitation expected to follow after further planning and budget allocation.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Biomerieux Microbiology Testing SuppliesThe contract forecast titled FY26 FR0 DFS/PHL - Biomerieux Microbiology Testing Supplies pertains to the procurement of microbiology testing supplies through the Forensic Sciences Division of the District of Columbia. It is scheduled for release in fiscal year 2026 with a posted date of July 23, 2026, indicating it is a preliminary announcement for future acquisition activity. The supplies are expected to support forensic microbiology testing operations, likely involving diagnostic reagents, culture media, consumables, or related laboratory materials from Biomerieux, a recognized provider in clinical and forensic microbiology diagnostics. There is no specific solicitation number assigned at this stage, and details such as NAICS code, set aside type, agency organization structure, and physical location of performance are not yet defined. The point of contact information is also unavailable, and the place of performance remains unspecified. This forecast serves as an early notice to potential vendors that a procurement for microbiology testing supplies is anticipated, allowing industry participants to prepare for future bidding opportunities under the District of Columbia’s forensic science contracting framework.

Forensic Sciences (DFS)

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Regulatory Compliance and Quality Assurance for Government ContractsThe contract requires strict adherence to multiple federal and military regulatory standards including MIL-STD-2073-1E for military packaging, Medical Marking Standard No. 1 for medical item identification, OSHA Hazard Communication Standard for chemical safety labeling, and DLA shelf-life compliance to ensure proper storage, tracking, and expiration management of pharmaceutical and medical supplies. All work must be performed with precision to meet government quality expectations, including comprehensive pre-shipment audits to verify labeling, packaging integrity, documentation accuracy, and expiration date validation prior to dispatch. The contractor is also obligated to support and facilitate destination inspections, ensuring seamless acceptance by government receiving authorities and prompt resolution of any compliance discrepancies. All services must be delivered to the place of performance at APO 09227-0000 under the agency designation of the Department of Defense’s Medical Supply Chain Pharm FSA. The solicitation is classified as a subcontract with NAICS code 541611, indicating it falls under management consulting services related to regulatory and quality assurance. Responses are due by August 3, 2026, with the solicitation posted on July 26, 2026, and all obligations are tied to maintaining the integrity of the Defense Logistics Agency’s supply chain for critical medical materiel.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Temperature-Controlled International Logistics and Sea TransportThe contract mandates the end-to-end ocean transport of temperature-sensitive hazardous pharmaceuticals to Germany using U.S.-flagged vessels unless a formal waiver is granted, with strict adherence to maintaining a cold chain between 20 and 25 degrees Celsius throughout transit. All shipments must comply with the International Maritime Dangerous Goods regulations and operate under FOB destination terms, meaning title and risk transfer to the consignee upon arrival at the German port. The work is classified under NAICS code 488991 and is structured as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance centered at APO 09227-0000. Bids must be submitted by August 3, 2026, and the solicitation was posted on July 26, 2026, emphasizing the need for specialized logistics expertise in handling regulated, perishable medical cargo under international maritime safety and temperature control standards.

Packing and Crating

POSTED

DEADLINE

Regulatory-Compliant Medical Labeling and MarkingThe contract requires the application of GHS-compliant labeling to pharmaceutical units and shipping containers in alignment with Medical Marking Standard No. 1 and OSHA’s Hazard Communication Standard, ensuring all hazard communication requirements are met across the supply chain. This includes the preparation of Safety Data Sheets and securing necessary government approvals to maintain regulatory compliance throughout handling, storage, and transport. All labeling and documentation must reflect accurate hazard information, proper pictograms, signal words, and precautionary statements in accordance with international and U.S. regulatory frameworks. The work is to be performed at APO, 09227-0000, under a subcontract classified under NAICS code 541690, which pertains to other scientific and technical consulting services. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. Bidders must adhere strictly to specified standards and timelines, as non-compliance could impact the safety and regulatory status of pharmaceutical shipments within federal supply networks.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Hazardous Pharmaceutical Packaging and PreservationThe contract requires the military-standard packaging and preservation of a hazardous, temperature-sensitive pharmaceutical in full compliance with MIL-STD-2073-1E and DLA RP001 specifications. This includes sealing each pharmaceutical unit in protective containers designed to maintain product integrity during transport under demanding environmental conditions, ensuring safety and regulatory adherence throughout the supply chain. All packaging processes must account for the material’s hazardous nature and thermal sensitivity, with strict controls to prevent contamination, degradation, or compromise during handling and transit. The work is to be performed at APO, zip code 09227-0000, under a subcontract agreement issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026. The North American Industry Classification System code 325412 indicates the activity pertains to pharmaceutical and medicinal product manufacturing, aligning the scope with specialized production and packaging capabilities. The terms demand precise execution under federal defense standards, emphasizing reliability, traceability, and security in the handling of critical medical materiel.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Domestic and International Medical Logistics & Freight ShippingThe contract requires comprehensive transportation and logistics management for Sodium Chloride Injection shipments, ensuring end-to-end handling from origin to destination under strict regulatory standards. All shipments must comply with U.S.-flag vessel requirements for international transport and adhere to MIL-STD-2073-1E for packaging, handling, and storage to maintain the integrity and sterility of the medical product. The scope encompasses both domestic and international freight operations, demanding coordination across multiple modes of transport and strict environmental controls to meet pharmaceutical shipping benchmarks. The contract is structured as a subcontract under the Department of Defense’s Medical Supply Chain PHSA, with performance centered at Fort Bragg, North Carolina, 28310. It was posted on July 26, 2026, with responses due by August 3, 2026. The North American Industry Classification System code 484121 indicates a focus on general freight trucking, underscoring the need for specialized ground and maritime logistics capabilities. The solicitation does not specify a set-aside classification, and all bidders must demonstrate proven experience in secure, compliant medical cargo logistics, particularly for Defense Department supply chains.

General Freight Trucking, Long-Distance, Truckload

POSTED

DEADLINE

Hazardous Material Packaging and Labeling ServicesThe contract requires the provision of OSHA Hazard Communication Standard-compliant hazard labeling and GHS-formatted safety data sheets for pharmaceutical shipments destined for the Defense Logistics Agency. All documentation must meet strict regulatory standards to ensure safe handling, storage, and transportation of hazardous materials, with full alignment to international and domestic chemical safety requirements. The work is focused on delivering accurate, up-to-date regulatory documentation that supports secure logistics operations for pharmaceuticals under military supply chain protocols. Performance is to be conducted in support of operations at Fort Bragg, North Carolina, with all deliverables tied to compliance, timeliness, and precision in labeling and documentation. The contract falls under NAICS code 541690, indicating it involves other scientific and technical consulting services, and is structured as a subcontract within the Department of Defense’s Medical Supply Chain Pharmaceutical FSA framework. Responses are due by August 3, 2026, and the solicitation is open through the DIBBS platform for potential contractors seeking to fulfill these critical regulatory and logistical support functions.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Sodium Chloride Injection (250 mL) SupplyThe contract calls for the supply of FDA-approved, sterile Sodium Chloride Injection, USP, in 250 mL flexible bags, manufactured and packaged to meet stringent USP standards, MMS NO. 1 specifications, and DLA labeling requirements. The product must be suitable for intravenous use and fully compliant with federal regulatory and procurement guidelines for medical supplies within the Department of Defense. All lots must be sterile, pyrogen-free, and consistently meet the quality benchmarks set by the United States Pharmacopeia to ensure patient safety and clinical efficacy. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is structured as a subcontract through the Medical Supply Chain Pharm FSA. Responses are due by August 3, 2026, with performance expected to support logistics operations centered at Fort Bragg, North Carolina, under the 28310 zip code. The contract is managed by the Department of Defense and will be administered through the DLA network, requiring strict adherence to packaging, labeling, and documentation standards mandated by DLA to ensure seamless integration into military medical supply chains.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Regulatory Compliance and Cybersecurity SupportThe contract seeks support for implementing and assessing cybersecurity controls aligned with NIST SP 800-171 and ensuring compliance with DFARS 252.204-7012, specifically focused on safeguarding covered defense information within the Department of Defense ecosystem. The contractor will be responsible for evaluating existing systems, identifying gaps in security controls, and providing actionable recommendations to achieve full compliance, including establishing processes for timely cyber incident reporting as mandated by federal regulations. This effort is critical to maintaining the integrity and confidentiality of sensitive defense data handled by the Medical Supply Chain Pharm FSA. Performance of this subcontract is required at Fort Bragg, North Carolina, with a response deadline of August 3, 2026, and is classified under NAICS code 541611 for management consulting services. The work involves close coordination with government personnel to ensure all technical and procedural requirements are met, with an emphasis on documentation, training, and continuous monitoring to sustain compliance. As a subcontract under the Department of Defense, the successful bidder must demonstrate proven experience in defense cybersecurity frameworks and be prepared to operate within a high-security, regulated environment where adherence to federal standards is non-negotiable.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Medical Logistics and Distribution ServicesThe contract solicits end-to-end transportation and delivery of pharmaceuticals to Fort Bragg, North Carolina, with strict requirements for maintaining chain-of-custody throughout the logistics process and implementing comprehensive risk management protocols to ensure product integrity and security. All services must comply with WAWF invoicing standards, ensuring accurate, timely, and automated financial reporting aligned with Department of Defense directives. The work falls under NAICS code 484121, indicating a focus on truck transportation of commodities, and is classified as a subcontract under the Medical Supply Chain Pharm FSA, a division of the Department of Defense. The solicitation was posted on July 26, 2026, with responses due by August 3, 2026, and performance is geographically limited to the Fort Bragg area, with zip code 28310 as the designated place of performance.

General Freight Trucking, Long-Distance, Truckload

POSTED

DEADLINE

Pharmaceutical Supplier – Dantrolene Sodium for InjectionThe contract solicits the supply of sterile, lyophilized Dantrolene Sodium for Injection, USP, specifically designated for emergency medical use and required to meet stringent regulatory standards including FDA compliance, current Good Manufacturing Practices, and defined shelf-life parameters. The product must be manufactured and packaged to ensure stability, purity, and readiness for immediate deployment in critical care scenarios, with all documentation and labeling adhering to federal pharmaceutical requirements. This is a subcontract under the Department of Defense, managed by the MEDICAL SUPPLY CHAIN PHARM FSA, with performance required at Fort Bragg, North Carolina, 28310. The solicitation was posted on July 26, 2026, with a response deadline of August 3, 2026, targeting qualified pharmaceutical suppliers capable of meeting the technical, regulatory, and logistical demands of emergency medical procurement. The North American Industry Classification System code 325412 indicates the scope is within pharmaceutical preparation manufacturing. There is no set-aside designation specified, and the opportunity is open to eligible subcontractors with proven capacity to deliver compliant, high-integrity Dantrolene Sodium products in a timely and reliable manner, ensuring continuous availability for military and emergency medical operations.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Quality Inspection at DestinationThe contract requires third-party inspection and acceptance of hazardous material packages at their destination, ensuring all deliveries meet strict regulatory standards. Inspectors must verify the physical integrity of packaging, confirm the accuracy and completeness of hazard labels, and validate that Material Safety Data Sheets are fully documented and up to date. Compliance with FED-STD-313 and IP025 is mandatory, requiring adherence to federal and industry-specific protocols for the handling and documentation of dangerous goods. The work is to be performed at FPO with ZIP code 09583, though the exact physical location within the area is not specified. This is a subcontract under NAICS code 541690, issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026. While no set-aside designation is listed, the opportunity is open to qualified subcontractors capable of performing specialized hazardous materials inspection services. All inspections must be conducted with precision and thorough documentation to ensure regulatory compliance and supply chain safety for sensitive medical and defense-related shipments.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Hazardous Materials Transportation and FOB Delivery ServicesThe contract requires the transport and delivery of packaged hazardous materials to designated military installations including Fort Stewart Georgia Fort Bragg North Carolina and the USS Delaware via FPO address with strict adherence to the fastest traceable shipping method explicitly excluding parcel post. All operations must comply with the Defense Federal Acquisition Regulation Supplement DFARS 252.247 7023 and the specific military standard IP025 ensuring full regulatory and safety compliance for hazardous material handling. Delivery must be executed under FOB terms with full accountability and documentation throughout the supply chain to guarantee timely and secure transport to sensitive defense locations. The solicitation titled Hazardous Materials Transportation and FOB Delivery Services is classified as a subcontract under NAICS code 484220 and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. The solicitation was posted on July 26 2026 with a response deadline of August 3 2026. Performance is centered on the FPO location with a zip code of 09583 and the opportunity is accessible through the DIBBS procurement portal. There is no set aside designation indicated and no point of contact information is provided in the data. All responders must ensure full regulatory compliance and operational readiness to meet the security and timing requirements for hazardous materials delivery to active military sites.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE